CC(C)n1cnc2c(N(C)c3cccc(Cl)c3)nc(N(CCO)CCO)nc21
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?